Literature DB >> 17616444

Is there a role for influenza vaccination in cystic fibrosis?

Dennis Wat1, Colin Gelder, Sam Hibbitts, Ian Bowler, Marcus Pierrepoint, Rachel Evans, Iolo Doull.   

Abstract

BACKGROUND: Influenza vaccination is generally recommended to patients with Cystic Fibrosis (CF). Previous studies have shown that influenza infections cause worsening lung functions, disease progression and increase propensity of bacterial infections in CF. However, the clinical evidence in the effectiveness of influenza vaccination in CF is lacking. AIMS: This study retrospectively reviewed the influenza vaccination status in the patients with CF and compared the influenza infection rates between the vaccinated and non-vaccinated groups. Finally the factors associated with non-adherence with vaccination were determined.
METHODS: Nasal swabs were obtained from 63 patients with CF between the age of 6 months to 18 years routinely and during respiratory exacerbations between October 2003 to April 2004. Influenza A and Influenza B were detected using Nucleic Acid Sequence Based Amplification (NASBA). The influenza vaccination status of these patients was retrospectively reviewed.
RESULTS: 41 patients (65%) were vaccinated against influenza. For the 22 patients (35%) who were not vaccinated, 7 of them were scared of needles leading to non-adherence. Influenza virus was detected on 5 occasions; 3 were Influenza A (60%) and 2 were Influenza B (40%). 1 virus in the vaccinated group and 4 in the non-vaccinated were detected during the study period (p-value=0.046).
CONCLUSIONS: Although the current available evidence to support routine influenza vaccination is limited in CF, this study has shown that such practice may yet play a role in preventing its subsequent acquisition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616444     DOI: 10.1016/j.jcf.2007.05.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  10 in total

Review 1.  Spectrum of viral infections in patients with cystic fibrosis.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

2.  Palivizumab, pneumococcal and influenza vaccination in cystic fibrosis.

Authors:  Mukta Jain; Anne H Thomson
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

Review 3.  The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications.

Authors:  Yvonne J Huang; Susan V Lynch
Journal:  Expert Rev Respir Med       Date:  2011-12       Impact factor: 3.772

4.  Influenza-associated cystic fibrosis pulmonary exacerbations.

Authors:  Justin R Ortiz; Kathleen M Neuzil; John C Victor; Anna Wald; Moira L Aitken; Christopher H Goss
Journal:  Chest       Date:  2009-12-04       Impact factor: 9.410

5.  Influenza vaccination among household contacts of children with cystic fibrosis and healthy children.

Authors:  Karen Kam; Athena McConnell
Journal:  Paediatr Child Health       Date:  2013-11       Impact factor: 2.253

6.  A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.

Authors:  Eric T Weimer; Haiping Lu; Nancy D Kock; Daniel J Wozniak; Steven B Mizel
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

7.  Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study.

Authors:  Ranjani Somayaji; Christopher H Goss; Umer Khan; Moni Neradilek; Kathleen M Neuzil; Justin R Ortiz
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

8.  Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.

Authors:  Sasan Tavana; Hassan Argani; Sharareh Gholamin; Seyed-Mostafa Razavi; Marzieh Keshtkar-Jahromi; Amir S Talebian; Keivan G Moghaddam; Zahra Sepehri; Talat M Azad; Maryam Keshtkar-Jahromi
Journal:  Influenza Other Respir Viruses       Date:  2011-09-28       Impact factor: 4.380

Review 9.  Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.

Authors:  Vanitha A Jagannath; G V Asokan; Zbys Fedorowicz; Tim W R Lee
Journal:  Cochrane Database Syst Rev       Date:  2016-02-24

10.  The role of respiratory viruses in cystic fibrosis.

Authors:  Dennis Wat; Colin Gelder; Sam Hibbitts; Fay Cafferty; Ian Bowler; Marcus Pierrepoint; Rachel Evans; Iolo Doull
Journal:  J Cyst Fibros       Date:  2008-02-06       Impact factor: 5.482

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.